Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Dec;76(6):2436–2439. doi: 10.1172/JCI112259

Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.

R A Galbraith, G S Drummond, A Kappas
PMCID: PMC424405  PMID: 4077989

Abstract

The ability of Sn(tin)-protoporphyrin to inhibit the induction of hepatic delta-aminolevulinate (ALA) synthase by allylisopropyl acetamide (AIA) was examined in the adult rat. Doses of Sn-protoporphyrin of 1, 10, and 50 mumol/kg body wt resulted in decreases in AIA-induced hepatic ALA-synthase activity of 32, 52, and 60%, respectively, compared with rats treated with AIA alone; inhibition of ALA-synthase was not a direct effect of Sn-protoporphyrin. This inhibition of the enzyme activity in liver was reflected in concurrent decreases in urinary excretion of ALA and porphobilinogen (PBG). The increased urinary excretion of ALA and PBG observed following AIA treatment was reduced by the lowest dose of Sn-protoporphyrin (1 mumol/kg body wt) and abolished completely by the higher doses of the metalloporphyrin (10 and 50 mumol/kg body wt). These findings in a rat model of hepatic porphyria suggest that Sn-protoporphyrin may be useful in the treatment of acute exacerbations of "inducible" hepatic porphyrias in man, especially since Sn-protoporphyrin, unlike hematin which is presently used for this purpose, is neither degraded by nor induces the activity of heme oxygenase.

Full text

PDF
2436

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson K. E., Simionatto C. S., Drummond G. S., Kappas A. Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase. J Pharmacol Exp Ther. 1984 Feb;228(2):327–333. [PubMed] [Google Scholar]
  2. Anderson K. E., Spitz I. M., Sassa S., Bardin C. W., Kappas A. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med. 1984 Sep 6;311(10):643–645. doi: 10.1056/NEJM198409063111006. [DOI] [PubMed] [Google Scholar]
  3. Bonkowsky H. L., Tschudy D. P., Collins A., Doherty J., Bossenmaier I., Cardinal R., Watson C. J. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2725–2729. doi: 10.1073/pnas.68.11.2725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. De Matteis F. Rapid loss of cytochrome P-450 and haem caused in the liver microsomes by the porphyrogenic agent 2-allyl-2-isopropylacetamide. FEBS Lett. 1970 Feb 25;6(4):343–345. doi: 10.1016/0014-5793(70)80094-1. [DOI] [PubMed] [Google Scholar]
  5. Drummond G. S., Kappas A. An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin. J Clin Invest. 1984 Jul;74(1):142–149. doi: 10.1172/JCI111394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Drummond G. S., Kappas A. Chemoprevention of neonatal jaundice: potency of tin-protoporphyrin in an animal model. Science. 1982 Sep 24;217(4566):1250–1252. doi: 10.1126/science.6896768. [DOI] [PubMed] [Google Scholar]
  7. Drummond G. S., Kappas A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc Natl Acad Sci U S A. 1981 Oct;78(10):6466–6470. doi: 10.1073/pnas.78.10.6466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Granick S., Sassa S., Granick J. L., Levere R. D., Kappas A. Assays for porphyrins, delta-aminolevulinic-acid dehydratase, and porphyrinogen synthetase in microliter samples of whole blood: applications to metabolic defects involving the heme pathway. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2381–2385. doi: 10.1073/pnas.69.9.2381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Granick S. The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem. 1966 Mar 25;241(6):1359–1375. [PubMed] [Google Scholar]
  10. KARIBIAN D., LONDON I. M. CONTROL OF HEME SYNTHESIS BY FEEDBACK INHIBITION. Biochem Biophys Res Commun. 1965 Jan 18;18:243–249. doi: 10.1016/0006-291x(65)90747-3. [DOI] [PubMed] [Google Scholar]
  11. Kappas A., Drummond G. S., Sardana M. K. Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver. J Clin Invest. 1985 Jan;75(1):302–305. doi: 10.1172/JCI111689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kappas A., Drummond G. S., Simionatto C. S., Anderson K. E. Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin. Hepatology. 1984 Mar-Apr;4(2):336–341. doi: 10.1002/hep.1840040227. [DOI] [PubMed] [Google Scholar]
  13. Kappas A., Simionatto C. S., Drummond G. S., Sassa S., Anderson K. E. The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin. Proc Natl Acad Sci U S A. 1985 Feb;82(3):896–900. doi: 10.1073/pnas.82.3.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Klinger W., Müller D. The influence of allyl isopropyl acetamide on d-aminolevulinic acid synthetase and cytochrome P-450. Acta Biol Med Ger. 1980;39(1):107–112. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Lamon J. M., Frykholm B. C., Hess R. A., Tschudy D. P. Hematin therapy for acute porphyria. Medicine (Baltimore) 1979 May;58(3):252–269. doi: 10.1097/00005792-197905000-00005. [DOI] [PubMed] [Google Scholar]
  17. MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
  18. McColl K. E., Thompson G. T., Moore M. R., Goldberg A. Haematin therapy and leucocyte delta-aminolevulinic-acid-synthase activity in prolonged attack of acute porphyria. Lancet. 1979 Jan 20;1(8108):133–134. doi: 10.1016/s0140-6736(79)90522-1. [DOI] [PubMed] [Google Scholar]
  19. Sassa S., Drummond G. S., Bernstein S. E., Kappas A. Long-term administration of massive doses of Sn-protoporphyrin in anemic mutant mice (sphha/sphha). J Exp Med. 1985 Sep 1;162(3):864–876. doi: 10.1084/jem.162.3.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sassa S., Granick S. Induction of -aminolevulinic acid synthetase in chick embryo liver cells in cluture. Proc Natl Acad Sci U S A. 1970 Oct;67(2):517–522. doi: 10.1073/pnas.67.2.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sassa S., Kappas A., Bernstein S. E., Alvares A. P. Heme biosynthesis and drug metabolism in mice with hereditary hemolytic anemia. Heme oxygenase induction as an adaptive response for maintaining cytochrome P-450 in chronic hemolysis. J Biol Chem. 1979 Feb 10;254(3):729–735. [PubMed] [Google Scholar]
  22. Simionatto C. S., Anderson K. E., Drummond G. S., Kappas A. Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production. J Clin Invest. 1985 Feb;75(2):513–521. doi: 10.1172/JCI111727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Simionatto C. S., Anderson K. E., Sassa S., Drummond G. S., Kappas A. Fluorometric measurement of tin-protoporphyrin in biological samples. Anal Biochem. 1984 Aug 15;141(1):213–219. doi: 10.1016/0003-2697(84)90448-2. [DOI] [PubMed] [Google Scholar]
  24. Srivastava G., Borthwick I. A., Brooker J. D., Wallace J. C., May B. K., Elliott W. H. Hemin inhibits transfer of pre-delta-aminolevulinate synthase into chick embryo liver mitochondria. Biochem Biophys Res Commun. 1983 Nov 30;117(1):344–349. doi: 10.1016/0006-291x(83)91582-6. [DOI] [PubMed] [Google Scholar]
  25. Stein J. A., Tschudy D. P. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore) 1970 Jan;49(1):1–16. [PubMed] [Google Scholar]
  26. Tschudy D. P., Valsamis M., Magnussen C. R. Acute intermittent porphyria: clinical and selected research aspects. Ann Intern Med. 1975 Dec;83(6):851–864. doi: 10.7326/0003-4819-83-6-851. [DOI] [PubMed] [Google Scholar]
  27. Unseld A., de Matteis F. Destruction of endogenous and exogenous haem by 2-allyl-2-isopropylacetamide: role of the liver cytochrome P-450 which is inducible by phenobarbitone. Int J Biochem. 1978;9(12):865–869. doi: 10.1016/0020-711x(78)90061-7. [DOI] [PubMed] [Google Scholar]
  28. WELLAND F. H., HELLMAN E. S., GADDIS E. M., COLLINS G., HUNTER G. W., Jr, TSCHUDY D. P. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET. Metabolism. 1964 Mar;13:232–250. doi: 10.1016/0026-0495(64)90103-9. [DOI] [PubMed] [Google Scholar]
  29. Yamamoto M., Hayashi N., Kikuchi G. Evidence for the transcriptional inhibition by heme of the synthesis of delta-aminolevulinate synthase in rat liver. Biochem Biophys Res Commun. 1982 Apr 14;105(3):985–990. doi: 10.1016/0006-291x(82)91067-1. [DOI] [PubMed] [Google Scholar]
  30. Yamamoto M., Hayashi N., Kikuchi G. Regulation of synthesis and intracellular translocation of delta-aminolevulinate synthase by heme and its relation to the heme saturation of tryptophan pyrrolase in rat liver. Arch Biochem Biophys. 1981 Jul;209(2):451–459. doi: 10.1016/0003-9861(81)90302-7. [DOI] [PubMed] [Google Scholar]
  31. Yamamoto M., Hayashi N., Kikuchi G. Translational inhibition by heme of the synthesis of hepatic delta-aminolevulinate synthase in a cell-free system. Biochem Biophys Res Commun. 1983 Aug 30;115(1):225–231. doi: 10.1016/0006-291x(83)90993-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES